Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Grochow

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|February 1, 1997
An overview of the clinical pharmacology of topotecanM J Dennis, J H Beijnen, L B Grochow, et al.
Cancer Research|April 15, 1992
Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogueC B Hendricks, E K Rowinsky, L B Grochow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
A phase I study of menogaril in patients with advanced cancerT D Brown, R C Donehower, L B Grochow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Camptothecin analogues: studies from the Johns Hopkins Oncology CenterW J Slichenmyer, E K Rowinsky, L B Grochow, et al.
Journal of Chromatography. B, Biomedical Applications|May 19, 1995
Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole bloodL W Anderson, S M Ludeman, O M Colvin, et al.
The Journal of Surgical Research|September 1, 1989
A method for hepatic arterial perfusion studies in the ratT T Than, J V Sitzmann, S S Li, et al.
Journal of Neuroscience Methods|November 1, 1987
A reservoir model for repeated CSF access in the rabbitM A Samphilipo, S J Hassenbusch, L B Grochow, et al.
Cancer Treatment Reports|July 1, 1982
The course of nausea and vomiting after high-dose cyclophosphamideJ H Fetting, L B Grochow, M F Folstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Population pharmacokinetic model for topotecan derived from phase I clinical trialsJ M Gallo, P B Laub, E K Rowinsky, et al.
Cancer Treatment Reports|December 1, 1987
Phase I trial of taxol in patients with advanced cancerR C Donehower, E K Rowinsky, L B Grochow, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|February 1, 1997
An overview of the clinical pharmacology of topotecanM J Dennis, J H Beijnen, L B Grochow, et al.
Cancer Research|April 15, 1992
Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogueC B Hendricks, E K Rowinsky, L B Grochow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
A phase I study of menogaril in patients with advanced cancerT D Brown, R C Donehower, L B Grochow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Camptothecin analogues: studies from the Johns Hopkins Oncology CenterW J Slichenmyer, E K Rowinsky, L B Grochow, et al.
Journal of Chromatography. B, Biomedical Applications|May 19, 1995
Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole bloodL W Anderson, S M Ludeman, O M Colvin, et al.
The Journal of Surgical Research|September 1, 1989
A method for hepatic arterial perfusion studies in the ratT T Than, J V Sitzmann, S S Li, et al.
Journal of Neuroscience Methods|November 1, 1987
A reservoir model for repeated CSF access in the rabbitM A Samphilipo, S J Hassenbusch, L B Grochow, et al.
Cancer Treatment Reports|July 1, 1982
The course of nausea and vomiting after high-dose cyclophosphamideJ H Fetting, L B Grochow, M F Folstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Population pharmacokinetic model for topotecan derived from phase I clinical trialsJ M Gallo, P B Laub, E K Rowinsky, et al.
Cancer Treatment Reports|December 1, 1987
Phase I trial of taxol in patients with advanced cancerR C Donehower, E K Rowinsky, L B Grochow, et al.
Pageof 9